ORN — Orion Group Holdings Inc
—
NYSE ·
Industrials ·
Construction & Engineering ·
CIK 1402829 ·
Last close
$8.35
Market Cap
$338.14M
52W High
$17.40
52W Low
$8.08
ADV30
422,448
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 221,878,000 | 22,927,000 | -1,468,000 | -4,145,000 | 496,222,000 | 2,527,000 | 331,765,000 |
| Mar 2026 | 216,301,000 | 25,879,000 | -830,000 | 4,687,000 | 478,723,000 | 6,254,000 | 312,055,000 |
| Dec 2025 | 233,223,000 | 27,050,000 | 3,957,000 | -240,000 | 414,652,000 | 1,588,000 | 255,620,000 |
| Sep 2025 | 225,097,000 | 29,752,000 | 4,693,000 | 3,301,000 | 422,375,000 | 4,917,000 | 264,485,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$24,372,000
Investing CF
$-61,023,000
Financing CF
$39,143,000
CapEx
$-42,805,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.09
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-60,661,000
Inventory
$2,546,000
Receivables
$253,223,000
ST Investments
—
EBIT TTM
$5,361,000
Pretax Income TTM
$-2,285,000
Interest Exp TTM
$7,646,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$896,499,968
EBITDA
$32,971,000
Free Cash Flow
$-20,898,124
Enterprise Value
$539,203,904
Total Cash
$2,527,000
Total Debt
$162,695,008
Shares Out
40,495,290
Trailing EPS
$0.08
Book Value
$4.06
ROE
2.3%
ROA
1.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 852,260,000 | 12,143,000 | 2,488,000 | 414,652,000 | 255,620,000 | 159,032,000 | 28,066,000 |
| Dec 2024 | 796,394,000 | 8,623,000 | -1,644,000 | 417,317,000 | 266,638,000 | 150,679,000 | 12,676,000 |
| Dec 2023 | 711,778,000 | -8,195,000 | -17,875,000 | 416,893,000 | 295,418,000 | 121,475,000 | 17,178,000 |
| Dec 2022 | 748,322,000 | -13,000,000 | -12,612,000 | 367,155,000 | 229,355,000 | 137,800,000 | 9,565,000 |
TTM Snapshot
Revenues TTM
$752,280,000
NetIncome TTM
$1,528,000
OpCashFlow TTM
$0
Assets (Latest)
$414,652,000
Forward EPS
$0.45
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $7.50 · spot: $8.35 · call volume: 43 · put volume: 0
Expected Move to 2026-10-16:
±$2.38
(28.44%) —
implied range
$5.98 –
$10.73
· ATM straddle on $7.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DFH | Dream Finders Homes, Inc. | $356.96M | $10.88 | — |
| PHOE | Phoenix Asia Holdings Ltd | $409.32M | $18.95 | — |
| MTRX | MATRIX SERVICE CO | $272.45M | $9.63 | — |
| BBCP | Concrete Pumping Holdings, Inc. | $498.89M | $9.90 | — |
| MAGH | Magnitude International Ltd | $225.45M | $6.76 | — |
News headlines (Yahoo Finance, 1h cache)
Orion Group Holdings Announces Conference Participation
2026-09-22 12:01 · Yahoo
Orion Group Q2 Earnings Call Highlights
2026-07-30 06:03 · Yahoo
Orion Group Holdings Inc (ORN) Q2 2026 Earnings Call Highlights: Navigating Challenges with ...
2026-07-29 21:00 · Yahoo
Can Orion's Mission-Critical Projects Fuel Shareholder Gains?
2026-07-15 14:35 · Yahoo
Is Orion's 63% Rally in a Year Fully Priced in Its Growth Story?
2026-07-13 16:26 · Yahoo
ORYZON Receives European Medicines Agency Approval to Initiate the HOPE-2 Phase II Study of Vafidemstat for the Treatment of Phelan-McDermid Syndrome (PMS)
2026-09-28 12:00 · Yahoo
ORYZON to Participate in Upcoming Events in September and October
2026-09-10 12:00 · Yahoo
ORYZON Announces Notice of Allowance for U.S. Patent Application Covering Iadademstat Combination With Gilteritinib
2026-08-31 12:00 · Yahoo
ORN Q2 Earnings Call Ties Profit Reset to Marine Delays
2026-08-03 16:07 · Yahoo
EME Q2 Earnings Beat Estimates on Broad-Based Growth, Stock Up
2026-07-30 16:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.